Leukemia Home > Arzera

Were you looking for information about Arzerra? Arzera is a common misspelling of Arzerra.
Arzerra® (ofatumumab) is prescribed to treat chronic lymphocytic leukemia (CLL) in adults who failed to respond to certain to or cannot take other chemotherapy treatment. This medication comes as an intravenous (IV) infusion that is given by a healthcare provider. It is given once a week for eight weeks, followed by a dose once every four weeks for four doses.
Although some people may not have any problems with this medicine, most people who receive this drug will experience some type of side effect. Common reactions include infections, fever, and diarrhea.
(For more information on this medicine, click Arzerra. This full-length article offers a complete overview of this drug, including how it works, safety warnings, and general dosing instructions. You can also click any of the links in the box to the right for more specific information.)
Written by/reviewed by:
Last reviewed by: Kristi Monson, PharmD;
Last updated/reviewed:
List of references (click here):
Other Articles in This eMedTV Presentation




Related Channels

eMedTV Links
Copyright © 2006-2020 Clinaero, Inc.

eMedTV serves only as an informational resource. This site does not dispense medical advice or advice of any kind. Site users seeking medical advice about their specific situation should consult with their own physician. Click Terms of Use for more information.

This site complies with the HONcode standard for trustworthy health information:
verify here.